Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/27/2012 | US20120245108 Method of modulating complement factor b (cfb) expression in cells |
09/27/2012 | US20120245107 Methods of reducing the proliferation and viablility of microbial agents |
09/27/2012 | US20120245081 Fas peptide mimetics and uses thereof |
09/27/2012 | US20120245080 Mineral salt-sulfonic acid compositions and methods of use |
09/27/2012 | US20120245079 Treatment of Diseases Caused by Bacterial Exotoxins |
09/27/2012 | US20120245029 Novel phosph(on)ate- and sulf(on)ate-based phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents |
09/27/2012 | US20120244222 Osmotic mediated release synthetic nanocarriers |
09/27/2012 | US20120244216 Coated pharmaceutical capsule dosage form |
09/27/2012 | US20120244212 Enhanced method and composition for the treatment of hiv+ tuberculosis patients with anti-retroviral drugs and liposomal encapsulation for delivery of reduced glutathione |
09/27/2012 | US20120244206 Dual action, inhaled formulations providing both an immediate and sustained release profile |
09/27/2012 | US20120244194 Pharmaceutical Compositions Comprising Terbinafine |
09/27/2012 | US20120244191 Compositions and methods for controlling diseases in animals |
09/27/2012 | US20120244190 Vaccination of Sex Reversed Hybrid Tilapia (Oreochromis niloticus X O. aureus) With an Inactivated Vibrio vulnificus Vaccine |
09/27/2012 | US20120244189 Treatment of infections |
09/27/2012 | US20120244187 Adenovirus Infection In Animals |
09/27/2012 | US20120244185 Immunization strategy to prevent h1n1 infection |
09/27/2012 | US20120244183 Influenza viruses and uses thereof |
09/27/2012 | US20120244181 Creating bioengineered lymph nodes |
09/27/2012 | US20120244180 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same |
09/27/2012 | US20120244171 Cytotoxic benzodiazepine derivatives |
09/27/2012 | US20120244166 Neutralizing antibodies to hiv-1 and their use |
09/27/2012 | US20120244150 Anti-veev humanized antibody |
09/27/2012 | US20120244149 Benzoxazepin pi3k inhibitor compounds and methods of use |
09/27/2012 | US20120244144 Pertussis antibodies and uses thereof |
09/27/2012 | US20120244122 Peptides for the Treatment of HCV Infections |
09/27/2012 | US20120244121 Modulators of toll-like receptor 7 |
09/27/2012 | US20120244120 Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection |
09/27/2012 | US20120244119 Anti-infective agents and uses thereof |
09/27/2012 | US20120244118 Conjugates and compositions for immunotherapy and anti-tumoral treatment |
09/27/2012 | US20120244117 Method of reversing immune suppression of langerhans cells |
09/27/2012 | US20120244113 Immunogenic composition and methods |
09/27/2012 | US20120244097 Reversely thermo-reversible hydrogel compositions |
09/27/2012 | US20120244084 Herbal extracts and flavor systems for oral products and methods of making the same |
09/27/2012 | DE112009005041T5 Verfahren der Extraktzubereitung aus Longankern und die Anwendung des Longankernextrakts Methods of extract preparation from Long anchors and the application of the Long anchor extract |
09/27/2012 | CA2830616A1 Pharmaceutical composition for treating hepatic disease |
09/27/2012 | CA2830012A1 New conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanionic polypeptide for the treatment of aids |
09/27/2012 | CA2829931A1 Stabilized hypohalous acid solutions |
09/27/2012 | CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
09/26/2012 | EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile |
09/26/2012 | EP2502995A1 Pharmaceutical composition |
09/26/2012 | EP2502914A2 Modulators of ATP-binding cassette transporters |
09/26/2012 | EP2502912A2 Modulators of ATP-binding cassette transporters |
09/26/2012 | EP2502911A2 Modulators of ATP-binding cassette transporters |
09/26/2012 | EP2502076A2 Methods for detecting a mycobacterium tuberculosis infection |
09/26/2012 | EP2501709A2 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections |
09/26/2012 | EP2501679A1 Heterocyclic antiviral compounds |
09/26/2012 | EP2501397A2 Methods for producing an immune response to tuberculosis |
09/26/2012 | EP2501396A1 LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE |
09/26/2012 | EP2501395A1 Par-1 antagonists for use in the treatment or prevention of influenza virus type a infections |
09/26/2012 | EP2501386A1 Quadruple therapy useful for treating persons afflicted with the human immunodeficiency virus (hiv) |
09/26/2012 | EP2501378A1 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
09/26/2012 | EP2501377A1 Novel schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (hiv) |
09/26/2012 | EP2501376A2 Compositions for topical administration |
09/26/2012 | EP2501375A1 Antimicrobial compositions containing free fatty acids |
09/26/2012 | EP1773361B2 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality |
09/26/2012 | CN1914225B HCV NS-3 serine protease inhibitors |
09/26/2012 | CN1679929B Streptococcal c5a peptidase vaccine |
09/26/2012 | CN102695704A Indole derivatives and methods for antiviral treatment |
09/26/2012 | CN102695516A Eradicating agent and eradication method for helicobacter pylori |
09/26/2012 | CN102695509A Novel photosensitizer formulations for oral administration |
09/26/2012 | CN102690792A Anti-human immunodeficiency virus (HIV) gene engineering recombinant virus and preparation method thereof, and anti-HIV gene engineering medicament |
09/26/2012 | CN102690791A Method for generating porcine pseudorabies virus by culturing ST cell in microcarrier of bioreactor |
09/26/2012 | CN102690789A Hybridoma cell strain secreting tetanus exotoxin monoclonal antibody, monoclonal antibody prepared by same, Fab antibody and application |
09/26/2012 | CN102690368A Preparation method of yeast beta-1,3-D-glucan derivative |
09/26/2012 | CN102690366A Preparation method of plant polysaccharide sulfate with immune enhanced activity and anti-virus effect, as well as application |
09/26/2012 | CN102690350A Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
09/26/2012 | CN102690335A Polypeptide for effectively inhibiting activity of influenza virus polymerase |
09/26/2012 | CN102690334A Purification method of virus vaccine |
09/26/2012 | CN102690332A Novel glycopeptide antibiotic derivative and pharmaceutical composition, and preparation method and purpose thereof |
09/26/2012 | CN102690331A Monosaccharide glycopeptide derivative, pharmaceutical composition, preparation method and purpose thereof and preparation method of intermediate |
09/26/2012 | CN102690330A Tri-substituted glycopeptide derivative and pharmaceutical composition, and preparation method and purpose thereof |
09/26/2012 | CN102690327A Enterovirus 71 neutralized epitope polypeptide and application thereof |
09/26/2012 | CN102690326A Novel gossypol derivate with anti-HIV activity and preparation method thereof |
09/26/2012 | CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors |
09/26/2012 | CN102690275A Tetrahydrofuro-[3,4-c]pyranyl-4-ketone compound and its preparation method and use |
09/26/2012 | CN102690264A 2-phenyl-3-substituted-imidazo[1,2-a]pyridine derivatives and preparation method thereof |
09/26/2012 | CN102690262A Lead compound of targeting human La protein and purpose thereof in preparation of medicament for resisting hepatitis B virus |
09/26/2012 | CN102690247A Furan compound, preparation method and application of same |
09/26/2012 | CN102690240A Tolyltriazole alkene ether compounds and oxime ether compounds and preparation method and application thereof |
09/26/2012 | CN102688502A Preparation process for gene vaccines containing UreB and CagA protein of helicobacter pylori |
09/26/2012 | CN102688488A Mucosal adjuvant and its preparation method and use |
09/26/2012 | CN102688487A Production method of newcastle disease (ND), infectious bronchitis (IB), infectious bursal disease virus (IBD) and viral arthritis (VA) four-joint inactivated vaccine |
09/26/2012 | CN102688486A Production method of triple inactivated vaccine for newcastle disease, infectious bursal disease and viral arthritis |
09/26/2012 | CN102688485A Preparation method of porcine parvovirus inactivated vaccine |
09/26/2012 | CN102688484A Production method for an inactivated vaccine for type-C Clostridial enteritis |
09/26/2012 | CN102688483A Composition for treating dermatosis, preparation containing composition and preparation method thereof |
09/26/2012 | CN102688457A Medicament for treating chronic respiratory disease of chicken and preparation method thereof |
09/26/2012 | CN102688444A Chinese traditional medicine for treating upper respiratory tract infection and preparation method thereof |
09/26/2012 | CN102688429A Medicinal tincture for treating fungal diseases |
09/26/2012 | CN102688423A AIDS (Acquired Immune Deficiency Syndrome) prevention preparation |
09/26/2012 | CN102688417A Chinese medicinal composition for treating porcine reproductive and respiratory syndrome |
09/26/2012 | CN102688412A External paste for treating verruca plana |
09/26/2012 | CN102688401A Traditional Chinese medicine oral liquid of couch grass root for treating chronic hepatitis and preparation method thereof |
09/26/2012 | CN102688393A Traditional Chinese medicine for treating verruca plana and preparation method thereof |
09/26/2012 | CN102688389A Traditional Chinese medicine composition for treating swine high fever syndrome, feed, as well as preparation method and application of traditional Chinese medicine composition |
09/26/2012 | CN102688371A Tablet for dispelling wind, nourishing blood, clearing heat and removing dampness |
09/26/2012 | CN102688370A Oral liquid preparation replacing antibiotic and treating yellow scour of newborn piglets, preparation method thereof and usage |
09/26/2012 | CN102688351A Effective fractions of Belamcanda chinensis (L) DC., preparation method and application thereof |
09/26/2012 | CN102688346A Chinese medicinal oral liquid for treating influenza and preparation method thereof |
09/26/2012 | CN102688341A Chinese medicine oral liquid for controlling chicken infectious bursal disease and preparation method of Chinese medicine oral liquid |